New drug duo shows promise for tough-to-treat throat cancer

NCT ID NCT05563480

First seen Apr 08, 2026 · Last updated May 12, 2026 · Updated 4 times

Summary

This study tested a combination of two drugs, TQB2618 and penpulimab, in 47 people with advanced nasopharyngeal carcinoma that had returned or spread. Some participants had already tried standard treatments, while others were new to therapy. The goal was to see if the combo is safe and helps shrink tumors or slow cancer growth. This is not a cure, but aims to control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Guangxi Medical University Cancer Hospital

    Nanning, Guangxi, 530012, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, 510100, China

  • The Fifth Affiliated Hospital Sun Yat sen University

    Zhuhai, Guangdong, 519000, China

  • Union Hospital Tongji Medical College, Huazhong University Of Science And Technology

    Wuhan, Hubei, 430022, China

  • Xiangya Hospital Central South University

    Changsha, Hunan, 410078, China

Conditions

Explore the condition pages connected to this study.